<DOC>
	<DOCNO>NCT00302913</DOCNO>
	<brief_summary>This study prospective , single-center evaluation efficacy clopidogrel dose adjustment patient insufficient platelet inhibition elective coronary stent implantation .</brief_summary>
	<brief_title>Efficacy Adjusted Clopidogrel Dose Patients With Insufficient Platelet Inhibition</brief_title>
	<detailed_description>Background : The EXCELSIOR trial demonstrate 7-fold increased risk death , myocardial infarction target vessel reintervention within 30 day patient platelet inhibition median study cohort bolus dose 600 mg clopidogrel . The median platelet inhibition cohort 14 % optical aggregation stimulation 5 µM ADP . Aim : To evaluate efficacy clopidogrel dose adjustment patient insufficient platelet inhibition elective coronary stent implantation Methods : This prospective , single-center study evaluate antiplatelet effect 120 patient receive bolus dose 600 mg clopidogrel undergo elective coronary stent implantation . Platelet inhibition evaluate 24 hour , 14 28 day coronary intervention use optical aggregometry ( 5 µM ADP ) determination surface protein expression flow cytometry ( P-Selectin , gp55 , activate GP IIb/IIIa ) . If 24 hour coronary stent implantation optical aggregation &gt; 14 % , patient receive additional bolus dose 300 mg clopidogrel , follow daily dose 150 mg least 28 day . If optical aggregation point time ≤14 % patient receive daily dose 75 mg clopidogrel . No dose adjustment follow perform . Hypothesis : Adjustment clopidogrel dose patient insufficient platelet inhibition determine optical aggregometry provide comparable antiplatelet effect patient sufficient platelet inhibition coronary stent implantation .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients undergo elective coronary stenting Pretreatment bolus dose 600mg clopidogrel least 2 hour prior coronary stent implantation Pretreatment aspirin ≥ 100 mg per day least 7 day Age &gt; 18 year Written consent Troponin T admission &gt; 0.03 ng/mL Myocardial infarction fibrinolytic therapy within previous 14 day Cardiogenic shock Contraindication aspirin clopidogrel Oral anticoagulation Pretreatment heparin thienopyridine within previous 14 day Use GP IIb/IIIareceptor antagonist PCI Platelet count &lt; 100.000/µl Severe disorder coagulation system Severe impairment liver kidney function Cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Drug Resistance</keyword>
	<keyword>PCI</keyword>
</DOC>